Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

prnasiaJanuary 20, 2020

Tag: Bridge Biotherapeutics Inc. , BBT-176 , FDA IND Clearance

PharmaSources Customer Service